Molecular and Cellular Toxicology An Introduction.
Autor principal: | |
---|---|
Formato: | Electrónico eBook |
Idioma: | Inglés |
Publicado: |
Newark :
John Wiley & Sons, Incorporated,
2014.
|
Colección: | New York Academy of Sciences Ser.
|
Temas: | |
Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Cover
- Title Page
- Copyright
- Contents
- Foreword
- Preface
- Acknowledgements
- Abbreviations
- About the Companion Website
- Chapter 1 Background to Molecular and Cellular Toxicology
- 1.1 What do we mean by molecular and cellular toxicology?
- 1.2 Tissues and their maintenance
- 1.2.1 Stem cells
- 1.3 Tissue damage
- 1.3.1 Consequences of tissue injury
- 1.3.2 Reversible changes in cells and tissues
- 1.3.3 Irreversible changes in cells and tissues
- 1.4 Tissue responses to injury
- 1.4.1 Oxidative stress
- 1.4.2 Necrosis and apoptosis
- 1.4.3 Neoplasia
- 1.4.4 The initiation-promotion paradigm
- 1.5 Key concepts in toxicology
- 1.5.1 Risk and hazard
- 1.5.2 Variability and uncertainty
- 1.5.3 Threshold and non-threshold dose responses
- 1.5.4 The regulatory context
- 1.5.5 Limitations of whole animal studies
- 1.5.6 Use of human tissues in toxicology
- 1.6 Summing up
- Self-assessment questions
- Background Reading
- References
- Chapter 2 Individual Susceptibility to Toxic Chemicals
- 2.1 Introduction
- 2.2 Toxicogenetics and toxicogenomics
- 2.3 Genotyping and phenotyping
- 2.3.1 Genotyping
- 2.3.2 Phenotyping
- 2.3.3 Correlating genotype and phenotype
- 2.4 Polymorphic xenobiotic metabolism
- 2.4.1 Polymorphic xenobiotic metabolising enzymes
- 2.4.2 The role of xenobiotic metabolising polymorphisms in susceptibility to toxic agents
- 2.5 Study numbers and effect size
- 2.6 Recent developments
- 2.6.1 Genome-wide association studies
- 2.6.2 Collaborative programmes
- 2.7 The UK Biobank
- 2.8 Conclusions
- Self-assessment questions
- Background Reading
- References
- Chapter 3 'Omics Techniques
- 3.1 'Omics and bioinformatics
- 3.2 Transcriptomics
- 3.2.1 Methodology
- 3.2.2 Proof of principle
- 3.2.3 Hepatotoxicity
- 3.2.4 Extrahepatic toxicity
- 3.3 Proteomics
- 3.3.1 Methodology
- 3.4 Metabolomics/metabonomics
- 3.4.1 MS-based metabolomics
- 3.4.2 NMR-based metabolomics
- 3.5 Integrating different types of `omics data
- 3.5.1 'Omics in drug discovery
- 3.5.2 'Omics profiles as biomarkers of toxicity
- 3.6 Remaining issues with `omics approaches
- 3.7 Conclusions
- Self-assessment questions
- Background Reading
- References
- Chapter 4 In Vitro Methods for Predicting In Vivo Toxicity
- 4.1 In vitro toxicology
- 4.2 Tissue culture
- 4.2.1 Primary cell cultures
- 4.2.2 Established cell lines
- 4.3 Acute toxicity in vitro
- 4.3.1 Cytotoxicity testing
- 4.3.2 Choice of cell line
- 4.3.3 Liver
- 4.3.4 Skin
- 4.3.5 Eye
- 4.4 Repeated dose toxicity
- 4.5 Reproductive toxicity
- 4.6 Stem cell-derived systems
- 4.7 Conclusions
- Self-assessment questions
- Background Reading
- References
- Chapter 5 In Vitro Methods for Absorption, Distribution, Metabolism and Excretion
- 5.1 Why study ADME in vitro?
- 5.2 Absorption
- 5.2.1 Dermal penetration
- 5.2.2 Gastrointestinal absorption
- 5.3 Distribution